[HTML] frontiersin.org

[HTML][HTML] Design, synthesis, and antitumor activity of erlotinib derivatives

L Mao, ZZ Wang, Q Wu, X Chen, JX Yang… - Frontiers in …, 2022 - frontiersin.org
Nineteen erlotinib derivatives bearing different 1, 2, 3-triazole moieties were designed,
synthesized, and evaluated for their potential against different cancer cell lines. The …
被引用次数：8 相关文章
[HTML] nih.gov

[HTML][HTML] Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives

L Mao, ZZ Wang, Q Wu, X Chen, JX Yang… - Frontiers in …, 2022 - ncbi.nlm.nih.gov
Nineteen erlotinib derivatives bearing different 1, 2, 3-triazole moieties were designed,
synthesized, and evaluated for their potential against different cancer cell lines. The …

Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives.

LF Mao, ZZ Wang, Q Wu, X Chen, JX Yang… - Frontiers in …, 2022 - europepmc.org
Nineteen erlotinib derivatives bearing different 1, 2, 3-triazole moieties were designed,
synthesized, and evaluated for their potential against different cancer cell lines. The …

Design, Synthesis, and Antitumor Activity of Erlotinib Derivatives

LF Mao, ZZ Wang, Q Wu, X Chen… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Nineteen erlotinib derivatives bearing different 1, 2, 3-triazole moieties were designed,
synthesized, and evaluated for their potential against different cancer cell lines. The …